CCL2 and breast cancer: To further examine TNC and CCL2 interaction networks in the in vivo model of breast cancer, we assessed RNAseq data from mice grafted with TNC+ NT193 cells at both the early stage (3 weeks) and a later stage of the disease (11 weeks).